Velcade Side Effects
Compare Velcade Side Effects
Post Your Velcade Side Effect and Help Community!
List of Velcade Side Effects reported to Patientsville
Detailed Velcade Side Effects reported to Patientsville
Velcade Side Effects reported to FDA
Quick-Add Your Side Effect
Substances toxic to Health
Side Effects SurveyVelcade Side Effects summary
Total Velcade reports: 3650.Velcade FDA safety alerts: No.
Reported deaths: 1158 Reported hospitalizations: 2069.
How to use Velcade ?.
Ask a Health Expert about Velcade or Ask Patient Community about Velcade.
Post a question or leave a comment:
Comments to date: 1. Page 1 of 1.
Ryan Location unknown | 2:45am on Thursday, December 4th, 2008 |
Just completed 6 cycles of velcade for relapsed multiple myeloma. I had severe leg pains which kept me awake until onco and specialist physician prescribed lentogesic for the pain and a combo of lyrica and tegtretol for the neuropathy. It has made ... read more » | |
Velcade Poll Results
Have you experienced Velcade side effects?| Yes, Severe |  52% |
| Yes, Mild | 33% |
| Yes, Minor | 5% |
| No | 10% |
Velcade Side Effects reported on Patientsville.com
Velcade Side Effects Report #SELF464 -2008-06-01
VELCADE problem was reported on 2008-06-01
Patient reported the following VELCADE side effects:"\""ACUTE, CRONIC, SEVERE\"" NEUROPATHY (words of neurologist)Had transplant Aug. 08 and it has NOT improved- numb feet & lower legs/fingers - sometimes extreme pain (today\'s date Nov. 7,08"Read more
Velcade FDA reported side effects and reactions
| 2008 |
|---|
| DISEASE PROGRESSION, ANAEMIA, DEATH, ABDOMINAL PAIN, ANOREXIA |
| 2007 |
|---|
| ANAEMIA, DISEASE PROGRESSION, DEATH, ATRIAL FIBRILLATION, DIARRHOEA |
| 2006 |
|---|
| DISEASE PROGRESSION, ASTHENIA, ANAEMIA, ABDOMINAL PAIN, DIARRHOEA |
Velcade Side Effects reported to FDA
Showing 1-40 of 3650 Next >
Velcade Side Effects Report #5199966-4Physician from UNITED STATES reported VELCADE problem on Dec 19, 2006. Female patient was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, dyspnoea, hypercalcaemia, pneumonia
, respiratory failure. VELCADE dosage: 1.30 MG/M2, IV BOLUS. Patient died.Velcade Side Effects Report #5199974-3
VELCADE problem was reported by a Physician from UNITED STATES on Dec 18, 2006. Male patient, 52 years of age, was diagnosed with mantle cell lymphoma stage iv and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: haematuria, hydronephrosis, hyperkalaemia, nausea, oral intake reduced, prostatitis, pyelonephritis, renal failure acute, tumour lysis syndrome. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, BACTRIM, VALTREX, ARANESP. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5201097-1
Physician from FRANCE reported VELCADE problem on Dec 19, 2006. Male patient, 61 years of age, weighting 189.6 lb, was diagnosed with t-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, inappropriate antidiuretic hormone secretion. VELCADE dosage: 3.00 MG. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXIL, VINCRISTINE. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5201100-9
VELCADE problem was reported by a Physician from CANADA on Dec 19, 2006. Male patient, 38 years of age, weighting 267.9 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, disease progression, electrocardiogram t wave biphasic, pneumonia , pulmonary embolism , sepsis , sinus tachycardia. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5201279-9
Physician from FRANCE reported VELCADE problem on Dec 19, 2006. Male patient, 41 years of age, weighting 152.1 lb, was diagnosed with t-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. VELCADE dosage: 2.81 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, BLEOMYCIN, METHOTREXATE, PREDNISONE, BACTRIM. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5201283-0
VELCADE problem was reported by a Physician from FRANCE on Dec 19, 2006. Male patient, 87 years of age, was diagnosed with myelodysplastic syndrome and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: acute abdomen, body temperature increased, faecaloma, septic shock, urinary retention. VELCADE dosage: 1.50 MG/M2, INTRAVENOUS. During the same period patient was treated with ARACYTINE. Patient was hospitalized. Patient died on 09/25/2006.
Velcade Side Effects Report #5201627-X
Physician from RUSSIAN FEDERATION reported VELCADE problem on Dec 20, 2006. Female patient, 57 years of age, weighting 202.8 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatitis b , transaminases increased. VELCADE dosage: 3.50 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5201871-1
VELCADE problem was reported by a Physician from NETHERLANDS on Dec 21, 2006. Female patient, 59 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: encephalitis herpes, hepatitis viral, herpes virus infection. VELCADE dosage: unknown. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, MELPHALAN, OMEPRAZOLE, MORPHINE. Patient recovered.Velcade Side Effects Report #5201877-2
Physician from FRANCE reported VELCADE problem on Dec 21, 2006. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: photosensitivity reaction, skin hyperpigmentation. VELCADE dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, BLEOMYCIN, PREDNISONE, GRANOCYTE. Patient recovered.
Velcade Side Effects Report #5201878-4
VELCADE problem was reported by a Physician from ITALY on Dec 21, 2006. Male patient, 63 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bundle branch block left, fall, head injury, syncope. VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5201888-7
Physician from SPAIN reported VELCADE problem on Dec 20, 2006. Male patient was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity, transaminases increased. VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Velcade Side Effects Report #5201894-2
VELCADE problem was reported by a Physician from FRANCE on Dec 20, 2006. Male patient, 59 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: haemophilus infection. VELCADE dosage: 2.60 MG. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5201897-8
Physician from FRANCE reported VELCADE problem on Dec 20, 2006. Female patient, 65 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: fungal infection, haemoglobin decreased, hyperthermia, hypoxia, influenza like illness, lung disorder, platelet count increased, productive cough, pulmonary fibrosis . VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, MORPHINE SULPHATE, PARACETAMOL, LORAZEPAM. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5201903-0
VELCADE problem was reported by a Physician from RUSSIAN FEDERATION on Dec 20, 2006. Male patient, 66 years of age, weighting 187.4 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: abdominal pain , gastrointestinal motility disorder. VELCADE dosage: 2.60 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5201905-4
Health Professional from UNITED KINGDOM reported VELCADE problem on Dec 20, 2006. Male patient, 63 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation , circulatory collapse, fall, hypotension, lethargy. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with OMEPRAZOLE, CIPROFLOXACIN, TAMSULOSIN, SALBUTAMOL INHALANT, SERETIDE, ZOFRAN, VITAMIN BLET, PYRIDOXINE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5203384-X
VELCADE problem was reported by a Physician from JAPAN on Dec 26, 2006. Female patient, 64 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cyanosis. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 12/26/2006.Velcade Side Effects Report #5203398-X
Physician from JAPAN reported VELCADE problem on Dec 26, 2006. Male patient, 71 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: aspergillosis, blood alkaline phosphatase decreased, blood lactate dehydrogenase increased, blood urea increased, blood uric acid increased, febrile neutropenia, hyperkalaemia, hypocalcaemia, pleural effusion. VELCADE dosage: 1.40 MG/M2, INTRAVENOUS. During the same period patient was treated with GAMIMUNE. Patient recovered.Velcade Side Effects Report #5203399-1
VELCADE problem was reported by a Physician from JAPAN on Dec 26, 2006. Male patient, 70 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood calcium abnormal, gastric haemorrhage, oesophageal haemorrhage, pancytopenia, pyrexia. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 12/26/2006.Velcade Side Effects Report #5203416-9
Physician from JAPAN reported VELCADE problem on Dec 27, 2006. Male patient, 64 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia, lung injury, sepsis . VELCADE dosage: 1.30 MG/M2, UNK, INTRAVENOUS. Patient died.Velcade Side Effects Report #5203446-7
VELCADE problem was reported by a Physician from AUSTRALIA on Dec 27, 2006. Female patient, 60 years of age, weighting 211.6 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: hepatitis , pulmonary embolism , thrombocytopenia. VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, GLIMEPIRIDE, METFORMIN, CLODRONATE DI, SIMVASTATIN, PROTAPHANE MC. Patient was hospitalized and became disabled. Patient recovered.Velcade Side Effects Report #5203475-3
Physician from AUSTRALIA reported VELCADE problem on Dec 27, 2006. Female patient, 76 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: arrhythmia supraventricular, atrial fibrillation , cardiac failure, condition aggravated, confusional state, constipation , diarrhoea, dyspnoea, fatigue. VELCADE dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MS CONTIN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5203480-7
VELCADE problem was reported by a Consumer or non-health professional from SPAIN on Dec 27, 2006. Male patient, 75 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: asthenia, dyspnoea, neuropathy peripheral, spontaneous haematoma. VELCADE dosage: 3.50 MG UNK. During the same period patient was treated with UNIKET, NORVASC, PAROXETINE, OMEPRAZOLE, SUMIAL, ALOPURINOL, NEURONTIN, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient died on 11/20/2006.Velcade Side Effects Report #5203481-9
Physician from GERMANY reported VELCADE problem on Dec 22, 2006. Male patient, 69 years of age, weighting 211.6 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, blood albumin decreased, prothrombin time prolonged. VELCADE dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, ACETAMINOPHEN, MORPHINE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5203622-3
VELCADE problem was reported by a Physician from UNITED STATES on Dec 22, 2006. Male patient, 68 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection, blood albumin decreased, blood glucose increased, blood lactate dehydrogenase increased, cryoglobulinaemia, culture positive, enterococcal infection. VELCADE dosage: unknown. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE, INSULIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5203839-8
Physician from UNITED STATES reported VELCADE problem on Dec 22, 2006. Male patient, 57 years of age, weighting 144.2 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, decreased appetite, deep vein thrombosis , hypokalaemia, iiird nerve paralysis, meningitis cryptococcal, neuralgia, neuropathy peripheral. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS; 1.70 MG, INTRAVENOUS. During the same period patient was treated with ALOXI, ZOMETA, ARANESP, PHENERGAN, EMLA CREAM, DIFLUCAN. Patient was hospitalized and became disabled. Patient recovered.Velcade Side Effects Report #5203929-X
VELCADE problem was reported by a Physician from UNITED STATES on Dec 22, 2006. Male patient, 69 years of age, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: chills, infusion related reaction, nausea, pruritus, pyrexia, urticaria. VELCADE dosage: unknown. During the same period patient was treated with RITUXIMAB, VINCRISTINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, DIOVAN HCT, SINGULAIR. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5203932-X
Physician from UNITED STATES reported VELCADE problem on Dec 27, 2006. Male patient, 66 years of age, weighting 192.9 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: calcinosis, dyspnoea, electrocardiogram st-t change, hyperhidrosis, hypertrophic cardiomyopathy, hypotension, lung neoplasm, sepsis , stem cell transplant. VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5203969-0
VELCADE problem was reported by a Health Professional from UNITED KINGDOM on Dec 27, 2006. Male patient, 63 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, atrial fibrillation , circulatory collapse, fall, hypotension, lethargy, malaise, neutropenia. VELCADE dosage: 1.30 MG/MD, INTRAVENOUS. During the same period patient was treated with OMEPRAZOLE, CIPROFLOXACIN, TAMSULOSIN, SALBUTAMOL INHALANT, SERETIDE, ZOFRAN, VITAMIN BLET, PYRIDOXINE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5203974-4
Physician from AUSTRALIA reported VELCADE problem on Dec 22, 2006. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: pneumonia . VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ENOXAPARIN, ALODORM, LOSEC, MIRTAZAPINE, PERIACTIN, ACETAMINOPHEN, TRAMADOL. Patient was hospitalized. Patient died on 12/17/2006.Velcade Side Effects Report #5203976-8
VELCADE problem was reported by a Physician from THAILAND on Dec 22, 2006. Male patient, 63 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: endocarditis , staphylococcal infection, thrombophlebitis. VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5203982-3
Physician from FRANCE reported VELCADE problem on Dec 27, 2006. Male patient, 64 years of age, weighting 180.8 lb, was diagnosed with b-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: toxic skin eruption. VELCADE dosage: 3.00 MG, INTRAVENOUS. During the same period patient was treated with CEFIXIME CHEWABLE, CIPROFLOXACIN, ALLOPURINOL, BACTRIM, FOLIC ACID, ACETAMINOPHEN, METRONIDAZOLE, LOPERAMIDE. Patient recovered.
Velcade Side Effects Report #5206641-6
VELCADE problem was reported by a Physician from GERMANY on Dec 28, 2006. Female patient, 55 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: constipation , musculoskeletal pain, neck pain, pyrexia. VELCADE dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5206645-3
Physician from BELGIUM reported VELCADE problem on Dec 29, 2006. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, pulmonary embolism
. VELCADE dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5206647-7
VELCADE problem was reported by a Physician from JAPAN on Dec 28, 2006. Female patient, 64 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: arterial thrombosis limb, blood pressure decreased, cyanosis, hypoxia, myocardial infarction, necrosis. VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient died on 12/26/2006.Velcade Side Effects Report #5206648-9
Physician from FRANCE reported VELCADE problem on Jan 04, 2007. Male patient, 59 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: haemophilus infection. VELCADE dosage: 2.60 MG. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5206660-X
VELCADE problem was reported by a Physician from FRANCE on Jan 03, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter related infection, diabetes mellitus inadequate control. VELCADE dosage: 3.33 MG, INTRAVENOUS. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5206863-4
Physician from JAPAN reported VELCADE problem on Dec 27, 2006. Female patient, 31 years of age, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, interstitial lung disease, lung injury, pleural effusion, respiratory failure. VELCADE dosage: 1.30 MG/M2. Patient died.Velcade Side Effects Report #5207049-X
VELCADE problem was reported by a Physician from UNITED STATES on Dec 29, 2006. Male patient, 57 years of age, weighting 144.2 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, breakthrough pain, decreased appetite, deep vein thrombosis , eyelid ptosis, fatigue, hypokalaemia, iiird nerve paralysis, neuralgia. VELCADE dosage: unknown. During the same period patient was treated with ALOXI, ZOMETA, ARANESP, PHENERGAN, EMLA CREAM, DIFLUCAN. Patient recovered.Velcade Side Effects Report #5207337-7
Physician from ITALY reported VELCADE problem on Jan 04, 2007. Male patient, 70 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma
and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, intracranial aneurysm. VELCADE dosage: 2.40 MG, UNK,. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient died on 12/30/2006.Velcade Side Effects Report #5207987-8
VELCADE problem was reported by a Physician from FRANCE on Dec 29, 2006. Female patient, 56 years of age, was diagnosed with t-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: aplasia, oesophageal candidiasis. VELCADE dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, METHOTREXATE, MESNA, GRANOCYTE. Patient was hospitalized. Patient recovered.
Showing 1-40 of 3650 Next >
